Get started
444

GENETICS GENERATION ADVANCEMENT COR

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

4160 chart


Full chart

4160 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪2.26 B‬ TWD
Dividend yield (indicated)
0.57%
Price to earnings Ratio (TTM)
39.8
Basic EPS (TTM)
2.2 TWD
Net income (FY)
‪28.57 M‬ TWD
Revenue (FY)
‪592.50 M‬ TWD
Shares float
—
Beta (1Y)
0.53

About GENETICS GENERATION ADVANCEMENT COR


Sector
Health Services
Industry
Medical/Nursing Services
CEO
Cheng Hsien Tsai
Website
gga.asia
Headquarters
Taipei
Founded
2008
ISIN
TW0004160007
FIGI
BBG001W71XR3
Genetics Generation Advancement Corp. engages in the provision of genetic testing, molecular diagnostics, biotechnology services, personal health-related testing services, biological information services, and health care services. It offers testing, pre-implantation stage, prenatal stage, newborn medical examination, adult healthcare health management genetic testing, adult healthcare cancer pharmacogenetics testing and other related testing services. The company was founded on November 21, 2008 and is headquartered in Taipei, Taiwan.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 4160 is 84.8 TWD — it has decreased by −1.05% in the past 24 hours. Watch GENETICS GENERATION ADVANCEMENT COR stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange GENETICS GENERATION ADVANCEMENT COR stocks are traded under the ticker 4160.
4160 stock has risen by 3.41% compared to the previous week, the month change is a −3.64% fall, over the last year GENETICS GENERATION ADVANCEMENT COR has showed a 120.52% increase.
4160 reached its all-time high on Jul 19, 2024 with the price of 150.9 TWD, and its all-time low was 17.6 TWD and was reached on Nov 29, 2011. View more price dynamics on 4160 chart.
See other stocks reaching their highest and lowest prices.
4160 stock is 2.51% volatile and has beta coefficient of 0.53. Track GENETICS GENERATION ADVANCEMENT COR stock price on the chart and check out the list of the most volatile stocks — is GENETICS GENERATION ADVANCEMENT COR there?
Today GENETICS GENERATION ADVANCEMENT COR has the market capitalization of ‪2.26 B‬, it has increased by 7.12% over the last week.
Yes, you can track GENETICS GENERATION ADVANCEMENT COR financials in yearly and quarterly reports right on TradingView.
4160 net income for the last quarter is ‪19.21 M‬ TWD, while the quarter before that showed ‪18.18 M‬ TWD of net income which accounts for 5.61% change. Track more GENETICS GENERATION ADVANCEMENT COR financial stats to get the full picture.
Yes, 4160 dividends are paid annually. The last dividend per share was 0.51 TWD. As of today, Dividend Yield (TTM)% is 0.54%. Tracking GENETICS GENERATION ADVANCEMENT COR dividends might help you take more informed decisions.
GENETICS GENERATION ADVANCEMENT COR dividend yield was 1.24% in 2023, and payout ratio reached 42.83%. The year before the numbers were 1.66% and 42.95% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENETICS GENERATION ADVANCEMENT COR EBITDA is ‪73.23 M‬ TWD, and current EBITDA margin is 5.74%. See more stats in GENETICS GENERATION ADVANCEMENT COR financial statements.
Like other stocks, 4160 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENETICS GENERATION ADVANCEMENT COR stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENETICS GENERATION ADVANCEMENT COR technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENETICS GENERATION ADVANCEMENT COR stock shows the buy signal. See more of GENETICS GENERATION ADVANCEMENT COR technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.